RxDoctor Payments Data

Catherine Gregg

Nurse Practitioner · Upper St Clair, PANPI 1043958374

Payments from drug & device makers

$1,817in general payments, 2019–2025

Across 93 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$560
  • Sanofi$540
  • Pfizer$184
  • Phathom Pharmaceuticals, Inc.$172
  • Inspire Medical Systems, Inc.$134
  • Sanofi-aventis U.S. LLC$100
  • plus $128 from 3 others

What the payments were for

  • Food & beverage$1,71794%
  • Education$1006%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,817 in reported general payments places this provider in the 85th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$32,832
Medicare patients
328
Services billed
866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth24$3,088
Fluocinolone Acetonide Oil57$2,109
Ipratropium Bromide72$1,991
Azelastine Hcl49$1,780
Fluticasone Propionate183$1,725
Ofloxacin62$1,143
Omeprazole97$978
Famotidine80$887
Pantoprazole Sodium64$859
SynthroidLevothyroxine Sodium15$845
Levothyroxine Sodium47$434
Mupirocin60$366
Mometasone Furoate21$364
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav39$261
Methylprednisolone45$257

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$560$84515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,059 nurse practitioner providers in Pennsylvania.

Other nurse practitioner in Upper St Clair

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →